Skip to main content
. 2019 Jul 16;160(9):2165–2179. doi: 10.1210/en.2019-00271

Figure 2.

Figure 2.

VILPs and their potential role in diabetes and cancer. VILPs bind to IR (red), IGF1R (orange), and hybrid receptors (red and orange) of targeted cells via autocrine, paracrine, endocrine, and other signaling to affect the pathogenesis of diabetes and cancer.